《盈利預喜》上海復旦(01385.HK)料上半年淨利潤介乎5.1億至5.5億人幣 按年增1.6倍至1.8倍
上海復旦(01385.HK)公布,截至今年6月30日止六個月預計營業收入約為16.8億元人民幣(下同)至17.2億元,按年增長48.85%至52.39%;淨利潤料約為5.1億元至5.5億元,按年增長162.42%至183%。
增長因主要產品線收入實現增長;由於受疫情影響,研發節奏放緩,其他營運費用支出減少並抵銷;因實施限制性股票激勵計劃,總計攤銷股份支付費用約為7,370萬元;及研發技術團隊的職工薪酬以及股份支付費用均較上年同期顯著增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.